A bona fide technological and medical revolution has been announced that will “transform the lives” of some 150,000 people with type 1 autoimmune diabetes in England and Wales, with the other home nations to follow. As the JDRF, a type 1 diabetes charity, puts it: “By automating what is currently a manual process, HCL can lift the relentless burden and …
